The history of one of the world's biggest speciality and rare disease pharmaceutical companies Shire is known as one of the world's fastest growing specialty pharmaceutical companies. Today ...

It's not every company that can go from $7 million in revenues to more than $1.7 billion in 10 years, but that's precisely what Shire Pharmaceuticals, whose hub lies in Wayne, Pa., accomplished in the ...

Shire Pharmaceuticals has announced it will ... In this respect, Teva could be seen more as a specialty pharma company than a generics maker. Stephen Kaldor, president and CEO of the biotech ...

Before joining Galderma, Ornskov was CEO of pharma company Shire from 2013 to 2019. If approved by the FDA, the company expects to start rolling out atopic dermatitis drug in early 2025 and ...

Meanwhile, the value of five pharmaceutical companies fell in 2017 as Merck & Co, Celgene, GlaxoSmithKline (GSK), Allergan and Shire all saw their market capitalisation decline. But there was ...

Takeda Pharmaceutical ... half of the company’s revenue. Founded in 1781, Takeda is Japan’s largest drugmaker by revenue. Kim joined Takeda through its acquisition of Shire in 2019.